我是 LongbridgeAI，我可以總結文章信息。Kirby McInerney LLP 正在調查 HCA Healthcare 可能違反證券法的行為，此次調查源於該公司在 2026 年 7 月 14 日發佈的新聞稿，因不利的支付方組合變化而大幅下調全年利潤預期。此公告導致 HCA 的股價下跌近 7%。該公司鼓勵在此期間購買 HCA 證券的投資者與他們聯繫，以討論與正在進行的調查相關的權利
HCA SHAREHOLDER ALERT: HCA Healthcare, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
What Happened?
On July 14, 2026, HCA Healthcare issued a press release reporting its preliminary financial and operating results for the second quarter of 2026. Among other items, HCA Healthcare sharply lowered its full-2026 profit guidance, citing an unfavorable shift in the Company’s payer mix, driven by an increase in uninsured volume—primarily due to patients who had lost coverage on health insurance exchanges—which impacted revenue by approximately $400 million in the quarter. The Company lowered its forecast for 2026 earnings to between $28.70 and $30.50 a share and narrowed its revenue target to $77 billion to $79.5 billion from a prior $76.5 billion to $80 billion range. Adjusted earnings before interest, taxes, depreciation and amortization are targeted at between $15.4 billion and $16.1 billion, where HCA Healthcare previously anticipated $15.55 billion to $16.45 billion.
On this news, HCA Healthcare’s stock price fell $27.14 per share, or 6.95%, to close at $363.60 per share on July 14, 2026.
What Should I Do?
At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws. Click here to learn more about securities class actions.
If you purchased or otherwise acquired HCA Healthcare securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
[LEARN MORE ABOUT THE INVESTIGATION]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260803791643/en/